☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Pregabalin Prescribing Guidance

NHS England has written to CCGs, pharmacies and GP practices regarding prescribing of generic pregabalin.

Pregabalin as the brand Lyrica® is licensed for epilepsy, generalised anxiety disorder and neuropathic pain. The patent for the neuropathic pain indication extends until July 2017. Generic versions of pregabalin are likely to be imminently available but are only licensed for epilepsy and generalised anxiety disorder due to this patent.

The manufacturer of Lyrica® is currently in a dispute with a number of generic pharmaceutical suppliers. The Court has required that NHS England issue guidance in relation to the prescribing and dispensing of pregabalin. This guidance states:

"Pregabalin should only be prescribed for the treatment of neuropathic pain under the brand name Lyrica®® (unless there are clinical contra-indications or other special clinical needs e.g. patient allergic to an excipient, branded product unavailable etc which apply to Lyrica®®, when you should not prescribe Lyrica®® or pregabalin)".

Action: Clinicians should be aware of this guidance. Consideration should be given to what measures need to be taken to protect against allegations of patent infringement.

Share 'Pregabalin Prescribing Guidance' by emailShare 'Pregabalin Prescribing Guidance' on FacebookShare 'Pregabalin Prescribing Guidance' on TwitterShare 'Pregabalin Prescribing Guidance' on LinkedInShare 'Pregabalin Prescribing Guidance' on reddit


One Comment to “Pregabalin Prescribing Guidance”

  1. […] 2015, NHS England were required by the courts to issue advice that pregabalin must be prescribed a […]

    Pingback by Updated Pregabalin Prescribing Guidance - Prescribing Advice for GPs — July 17, 2017 #

Leave a Reply to Updated Pregabalin Prescribing Guidance - Prescribing Advice for GPs Cancel reply

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.